openPR Logo
Press release

Pharma Contract Research Organization (CRO) Services Market Growth: $52B in 2024 to $85B by 2034

12-03-2025 03:13 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Pharma Contract Research Organization (CRO) Services Market

Pharma Contract Research Organization (CRO) Services Market

The Pharma CRO Services market is expected to witness a robust CAGR of 6.1% from 2024 to 2034, driven by increased demand for outsourcing and rising drug development complexities.

Introduction:
The global Pharma Contract Research Organization (CRO) Services Market is projected to grow significantly, reaching $85 billion by 2034, up from $52 billion in 2024. This growth is primarily driven by the outsourcing trend within the pharmaceutical industry, the increasing complexity of drug development processes, and the rising demand for specialized research services.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72854

Key Takeaways:
• Market Size & Forecast:
o 2024: $52 billion
o 2034: $85 billion
o CAGR: 6.1%
• The market's expansion is supported by growing pharmaceutical R&D spending and a surge in demand for cost-effective services.

Key Players in the Market:
• IQVIA
• Parexel International
• Covance
• Medidata Solutions
• PRA Health Sciences
• Charles River Laboratories
• Labcorp Drug Development

Explore Full Report here:
https://exactitudeconsultancy.com/reports/72854/pharma-contract-research-organization-cro-services-market

Key Events in the Last 5 Years:
1. Increased Outsourcing: Pharmaceutical companies have increasingly relied on CROs for preclinical and clinical trial services, reducing the need for in-house capabilities.
2. Technological Advancements: Integration of AI and machine learning for data analytics and clinical trial management has improved CRO efficiency.
3. Strategic Mergers and Acquisitions: Leading CROs have formed alliances to enhance their service portfolios and geographic reach.

Market Growth Rate (CAGR & Forecast):
The Pharma CRO Services market is projected to grow at a CAGR of 6.1% from 2024 to 2034. Increasing investments in drug discovery and development, along with the rising trend of outsourcing R&D, will be key drivers of this growth.
Market Segments and Their Growth Analysis:

• By Service Type:
o Clinical Trial Management
o Regulatory Affairs
o Data Management
o Others
• By End-User:
o Pharmaceutical Companies
o Biotech Firms
o Medical Device Companies
• By Region:
o North America
o Europe
o Asia Pacific
o Rest of the World

Key Market Drivers:
1. Outsourcing of Research: CROs provide cost-effective and time-efficient services, making them essential partners for pharmaceutical firms.
2. Rising Drug Complexity: The increasing complexity of drug pipelines, especially biologics, is pushing pharmaceutical companies to seek specialized CRO services.
3. Regulatory and Compliance Needs: The growing number of regulations requires expertise that CROs can provide.
Conclusion:
The Pharma Contract Research Organization (CRO) Services Market is poised for substantial growth due to increasing outsourcing and the complex needs of drug development. With a projected market value of $85 billion by 2034, this sector will continue to evolve, offering vast opportunities for both established and emerging players.

This report is also available in the following languages : Japanese (製薬業界のCROサービス市場), Korean (製薬業界のCRO서비스시장), Chinese (制薬流行のCRO서비스시장), French (Marché des services des organismes de recherche sous contrat (CRO) pharmaceutiques), German (Markt für Auftragsforschungsinstitute (CRO) in der Pharmabranche), and Italian (Mercato dei servizi delle organizzazioni di ricerca a contratto (CRO) nel settore farmaceutico), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72854

Our More Reports:

Cholangiosarcoma Market
https://exactitudeconsultancy.com/reports/72868/cholangiosarcoma-market

TIL Therapy Market
https://exactitudeconsultancy.com/reports/72870/til-therapy-market

Vascular Disrupting Agents Market
https://exactitudeconsultancy.com/reports/72872/vascular-disrupting-agents-market

Friedreich's Ataxia Market
https://exactitudeconsultancy.com/reports/72874/friedreich-s-ataxia-market

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharma Contract Research Organization (CRO) Services Market Growth: $52B in 2024 to $85B by 2034 here

News-ID: 4299112 • Views:

More Releases from Exactitude Consultancy

Neuroendocrine Breast Tumor Market to Reach USD 4.5 Billion by 2034, Growing at a CAGR of 7.5%
Neuroendocrine Breast Tumor Market to Reach USD 4.5 Billion by 2034, Growing at …
Exactitude Consultancy's new report explores the growth of the Neuroendocrine Breast Tumor Market, driven by advancements in diagnostic methods, targeted therapies, and increasing research investments. Introduction: Exactitude Consultancy's latest market research report on the Neuroendocrine Breast Tumor Market forecasts strong growth from USD 2.3 billion in 2024 to USD 4.5 billion by 2034, growing at a CAGR of 7.5%. The market is driven by improvements in diagnostic technologies, increasing research into targeted
Cutaneous Lupus Market to Reach USD 2.6 Billion by 2034, Growing at a CAGR of 8.1%
Cutaneous Lupus Market to Reach USD 2.6 Billion by 2034, Growing at a CAGR of 8. …
Exactitude Consultancy's new report explores the increasing growth of the Cutaneous Lupus Market, driven by advancements in treatment options, diagnostic tools, and rising awareness. Introduction: Exactitude Consultancy's latest market research report on the Cutaneous Lupus Market forecasts significant growth from USD 1.2 billion in 2024 to USD 2.6 billion by 2034, growing at a CAGR of 8.1%. The market is driven by improvements in treatment strategies, increasing awareness of cutaneous lupus, and
Respiratory Syncytial Virus Prophylaxis Market to Reach USD 12 Billion by 2034, Growing at a CAGR of 9.5%
Respiratory Syncytial Virus Prophylaxis Market to Reach USD 12 Billion by 2034, …
Exactitude Consultancy's new report analyzes the Respiratory Syncytial Virus Prophylaxis Market, driven by advancements in monoclonal antibodies, vaccines, and preventive care strategies. Introduction: Exactitude Consultancy's latest report on the Respiratory Syncytial Virus Prophylaxis Market forecasts significant growth from USD 5.4 billion in 2024 to USD 12 billion by 2034, growing at a CAGR of 9.5%. The market is driven by increasing awareness, advancements in monoclonal antibody-based prophylaxis, and rising demand for vaccines
Erythropoietic Protoporphyria Market to Reach USD 1.05 Billion by 2034, Growing at a CAGR of 5.3%
Erythropoietic Protoporphyria Market to Reach USD 1.05 Billion by 2034, Growing …
Exactitude Consultancy's new report explores the growing Erythropoietic Protoporphyria Market, driven by advancements in therapeutic treatments and increased disease awareness. Introduction: Exactitude Consultancy's latest report on the Erythropoietic Protoporphyria Market forecasts strong growth from USD 620 million in 2024 to USD 1.05 billion by 2034, growing at a CAGR of 5.3%. The market is driven by rising awareness of the disorder, advancements in pharmacological treatments, and the development of new therapies. Download Full

All 5 Releases


More Releases for CRO

Contract Research Organization (CRO) Research: China CRO market size is projecte …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Contract Research Organization (CRO)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few
Global Veterinary CRO & CDMO Market Size & Trends
According to a new market research report published by Global Market Estimates, the global veterinary CRO & CDMO market is expected to grow at a CAGR of 9.1% from 2023 to 2028. The growing awareness regarding the importance of animal health and welfare has led to increased investments in veterinary pharmaceutical research and development. This awareness is driven by the rising concern for the well-being of pets, livestock, and animals used
Global Contract Research Organization (CRO) Services Market
According to a new market research report published by Global Market Estimates, the Global Contract Research Organization (CRO) Services Market is expected to grow at a CAGR of 10.2% from 2023 to 2028. The growth of the contract research organization (CRO) Services Market is fuelled by factors including the rising preference for outsourcing clinical trials, increasing investments in research and development by pharmaceutical and biopharmaceutical companies, the growing complexities in drug
Contract Research Organization (CRO) Services Market - Efficiency, Expertise, Ex …
Newark, New Castle, USA: The "Contract Research Organization (CRO) Services Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Contract Research Organization (CRO) Services Market: https://www.growthplusreports.com/report/contract-research-organization-cro-services-market/7630 This latest report
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial
Pracedo Promote Ellie Copp To CRO
Pracedo, a Mashfrog Group company that provides Salesforce consultancy and digital transformation to charities, NGOs, and enterprise customers, promotes Ellie Copp to Chief Revenue Officer. Pracedo announced Ellie Copp as its new Chief Revenue Officer (CRO). Ellie joined Pracedo in 2019 and most recently held the position of Sales and Marketing Director. As CRO, she will continue to lead the commercial teams by overseeing all revenue-generating activities as Pracedo continues